Role of letermovir therapeutic drug monitoring for cytomegalovirus prophylaxis in allogeneic hematopoietic stem cell transplantation recipients: a prospective study
DOI:
10.1007/s10096-024-04977-7
Publication Date:
2024-11-09T12:52:19Z
AUTHORS (11)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (36)
CITATIONS (2)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....